Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2813 of 5804
-
Memory coach helps early Alzheimer's patients stay independent
Symptom relief CompletedAlzheimer's disease (AD) is one of the leading causes of disability in older adults. Because pharmacological approaches do not seem to prevent or slow the disease, clinicians need non-pharmacological interventions that might help people with AD remain independent for as long as p…
Phase: NA • Sponsor: University of Delaware • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could hidden nerve damage explain pain in kids with developmental delays?
Knowledge-focused CompletedBackground: Small-Fiber-Neuropathy describes the degeneration of mildly or unmyelinated nerve fibers and causes neuropathic pain and autonomic dysfunction. Gold standard for the diagnosis is a small skin punch biopsy from the lower leg and the histological quantification of the i…
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Can exercise rewire the brain in people with movement disorders?
Symptom relief CompletedBalance and aerobic training show promise as treatments for degenerative cerebellar diseases, but the neural effects of both training methods are unknown. The goal of this project is to evaluate how each training method impacts the brain, and particularly, the degenerating cerebe…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a blood concentrate make cochlear implants work better?
Disease control Recruiting nowFibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the …
Phase: NA • Sponsor: Pamukkale University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Pharmacist-Led team aims to cut medication errors in Hospital-to-Nursing home transitions
Disease control CompletedThe Pharmacy Integrated Transitions (PIT) program, utilizes a crossover randomized control design to evaluate the impact of a clinical pharmacist in decreasing medication related problems during a patient's transition from hospital to skilled nursing facility (SNF).
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Hypnosis could take the fear out of colon cancer screening
Symptom relief Recruiting nowThrough this study, the effectiveness of hypnosis in the realization of a colonoscopy for the detection of colorectal cancer will be evaluated
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Experimental UC drug trial halted midway
Disease control TerminatedThe main purpose of this study is to evaluate the effect of efavaleukin alfa on induction of clinical remission in participants with moderately to severely active ulcerative colitis (UC). Participants will be randomized to receive 1 of 3 efavaleukin alfa doses or placebo during …
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New program boosts PrEP adherence in Stimulant-Using men
Prevention CompletedThis multi-site randomized controlled trial enrolling sexual minority men who use stimulants and are currently taking pre-exposure prophylaxis (PrEP). This randomized controlled trial will test the efficacy of a PrEP Affect Regulation Treatment Innovation (PARTI) condition compri…
Phase: NA • Sponsor: Florida International University • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New study examines immunotherapy outcomes in american indian cancer patients
Knowledge-focused OngoingThe aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to …
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Brain zaps for weight loss: new study tests magnetic therapy on cravings
Symptom relief CompletedThis doctoral dissertation takes into account epidemiological and clinical data of the international literature about obesity and, generally, increased body weight (BMI≥ 25kg/m2) and their consequences on health. Obesity management challenges many specialties, while, currently, t…
Phase: NA • Sponsor: Larissa University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can sound waves and a tiny dose of chemo train the body to fight breast cancer?
Disease control OngoingThis study will test the use of focused ultrasound ablation, low-dose gemcitabine (a chemotherapy) and the combination of focused ultrasound ablation plus low-dose gemcitabine in patients with early-stage breast cancers. We will be testing the effects of each of these regimens on…
Phase: PHASE1 • Sponsor: Patrick Dillon, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New nutrition program aims to help kids with autism eat their veggies
Disease control CompletedThere is an unmet need for nutrition interventions that address both autism spectrum disorder (ASD) specific feeding challenges and unbalanced eating habits among children with ASD to prevent future chronic health conditions. Children with ASD tend to consume few fruit and vegeta…
Phase: NA • Sponsor: University of South Florida • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Talking through problems eases cancer Caregivers' anxiety
Symptom relief CompletedThis study is a randomized clinical trial of a problem-solving therapy intervention for family caregivers of individuals with cancer receiving outpatient palliative care.
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can meaningful activities slow dementia's toll? new study explores tailored plans.
Symptom relief CompletedNeuropsychiatric symptoms are the most difficult, distressing, and burdensome aspects of dementia care and a catalyst for long-term care placement. Intervention studies have largely focused on helping caregivers manage these symptoms. However, little has been done with regard to …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can a probiotic tame hay fever? new study investigates
Symptom relief CompletedAllergic rhinitis (AR) is a health problem characterised by an inflammatory reaction in the nasal mucosa mediated by immunoglobulin (Ig) E and resulting from exposure to environmental allergens, such as pollen and dust mites. AR symptoms can significantly affect the quality of l…
Phase: NA • Sponsor: Fundació Eurecat • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New pill shows promise for Hard-to-Treat HER2 cancers
Disease control Recruiting nowTo evaluate the safety and tolerability of SPH5030 tablets in subjects with HER2-positive advanced solid tumors
Phase: EARLY_PHASE1 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New antibody drug takes on advanced tumors in first human trial
Disease control OngoingCHANCES-IPC 2021-008 is First In Human, Phase I, multicenter, European study evaluating an anti-CD73, IPH5301 in advanced and/or metastatic cancer. The trial will be conducted in two parts, Part I- Dose escalation: This part aims to identify the maximum tolerated dose (MTD) of I…
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New skin sensor could help sickle cell patients stay hydrated
Diagnosis Recruiting nowThis study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell dise…
Phase: NA • Sponsor: Enrico Novelli • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Could a zapping device help MS patients swallow safely?
Symptom relief CompletedDysphagia is a disabling, life-threatening symptom that can cause death in Multiple Sclerosis people (pwMS) through aspiration pneumonia. Speech therapists use behavioural therapies (compensatory and rehabilitative) to alleviate such swallowing problems, with limited benefit. Com…
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New Dual-Action antibody takes on advanced tumors
Disease control CompletedA multi-center, open phase Ia/Ib clinical study to evaluate the safety, tolerance, pharmacokinetics and preliminary clinical efficacy of BAT7104 injection in patients with advanced malignant tumors.
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC